Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system

Cytomegalovirus (CMV) has yielded many insights into immune escape mechanisms. Both human and mouse CMV encode a diverse array of gene products, many of which appear to modulate the immune response in the host. Some deflect the host response to infection and contribute to lifelong viral persistence while others exploit immune cells that respond to infection. Here, the viral functions that modulate and mimic host major histocompatibility complex (MHC) function will be reviewed. Viral gene products related to both classical and non‐classical components of the MHC system assure the virus will persist in immunocompetent individuals. Examples of host countermeasures that neutralize viral immunomodulatory functions have emerged in the characterization of viral functions that contribute to this stand‐off in CMVs that infect humans, other primates and rodents. CMV‐induced disease occurs when the immune system is not yet developed, such as in the developing fetus, or when it is compromised, such as in allograft transplant recipients, suggesting that the balance between virus escape and host control is central to pathogenesis. Although evidence supports the dominant role of immune escape in CMV pathogenesis and persistence, MHC‐related immunomodulatory functions have been ascribed only subtle impact on pathogenesis and the immune response during natural infection. Viral gene products that interface with the MHC system may impact natural killer cell function, antigen presentation, and T lymphocyte immune surveillance. Many also interact with other cells, particularly those in the myeloid lineage, with consequences that have not been explored. Overall, the virus‐encoded modulatory functions that have been acquired by CMV likely ensure survival and adaptation to the wide range of mammalian host species in which they are found.

[1]  U. Koszinowski,et al.  Murine Cytomegalovirus Interference with Antigen Presentation Has Little Effect on the Size or the Effector Memory Phenotype of the CD8 T Cell Response1 , 2004, The Journal of Immunology.

[2]  M. Groettrup,et al.  A Cytomegalovirus Inhibitor of Gamma Interferon Signaling Controls Immunoproteasome Induction , 2004, Journal of Virology.

[3]  B. Slobedman,et al.  A Novel Viral Transcript with Homology to Human Interleukin-10 Is Expressed during Latent Human Cytomegalovirus Infection , 2004, Journal of Virology.

[4]  V. Štolc,et al.  Functional profiling of a human cytomegalovirus genome , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Jonjić,et al.  Pathogenesis of murine cytomegalovirus infection. , 2003, Microbes and infection.

[6]  David C. Johnson,et al.  Human Cytomegalovirus US2 Causes Similar Effects on Both Major Histocompatibility Complex Class I and II Proteins in Epithelial and Glial Cells , 2003, Journal of Virology.

[7]  P. Bjorkman,et al.  Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor , 2003, Nature Immunology.

[8]  Kouhei Tsumoto,et al.  Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Sutherland,et al.  Human Cytomegalovirus Glycoprotein UL16 Causes Intracellular Sequestration of NKG2D Ligands, Protecting Against Natural Killer Cell Cytotoxicity , 2003, The Journal of experimental medicine.

[10]  L. Lanier,et al.  NKG2D-mediated Natural Killer Cell Protection Against Cytomegalovirus Is Impaired by Viral gp40 Modulation of Retinoic Acid Early Inducible 1 Gene Molecules , 2003, The Journal of experimental medicine.

[11]  D. Wolf,et al.  For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin–proteasome connection , 2003, The EMBO journal.

[12]  David C. Johnson,et al.  Viral inhibition of MHC class II antigen presentation. , 2003, Trends in immunology.

[13]  M. Menzies,et al.  Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers , 2003, Journal of Virology.

[14]  S. Riddell,et al.  Intracellular Retention of the MHC Class I-Related Chain B Ligand of NKG2D by the Human Cytomegalovirus UL16 Glycoprotein1 , 2003, The Journal of Immunology.

[15]  L. Brandén,et al.  The Human Cytomegalovirus Protein UL16 Mediates Increased Resistance to Natural Killer Cell Cytotoxicity through Resistance to Cytolytic Proteins , 2003, Journal of Virology.

[16]  J. Yewdell,et al.  A single viral protein HCMV US2 affects antigen presentation and intracellular iron homeostasis by degradation of classical HLA class I and HFE molecules. , 2003, Blood.

[17]  H. Reyburn,et al.  Expression of the UL16 glycoprotein of Human Cytomegalovirus protects the virus-infected cell from attack by natural killer cells , 2003, BMC Immunology.

[18]  A. Diefenbach,et al.  Innate immune recognition by stimulatory immunoreceptors. , 2003, Current opinion in immunology.

[19]  M. Smyth,et al.  Functional interactions between dendritic cells and NK cells during viral infection , 2003, Nature Immunology.

[20]  H. Rammensee,et al.  Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein , 2003, European journal of immunology.

[21]  U. Koszinowski,et al.  Effective Inhibition of Kb- and Db-Restricted Antigen Presentation in Primary Macrophages by Murine Cytomegalovirus , 2003, Journal of Virology.

[22]  J. Yewdell,et al.  Viral interference with antigen presentation , 2002, Nature Immunology.

[23]  P. Parham,et al.  NK cell-mediated lysis of autologous HCMV-infected skin fibroblasts is highly variable among NK cell clones and polyclonal NK cell lines. , 2002, Clinical immunology.

[24]  E. Mocarski,et al.  Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. , 2002, Blood.

[25]  Andrew J Davison,et al.  Fundamental and accessory systems in herpesviruses. , 2002, Antiviral research.

[26]  A. Scalzo Successful control of viruses by NK cells--a balance of opposing forces? , 2002, Trends in microbiology.

[27]  U. Koszinowski,et al.  Major Histocompatibility Complex Class I Allele-specific Cooperative and Competitive Interactions between Immune Evasion Proteins of Cytomegalovirus , 2002, The Journal of experimental medicine.

[28]  S. Riddell,et al.  Association between immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell response. , 2002, The Journal of infectious diseases.

[29]  E. Mocarski Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. , 2002, Trends in microbiology.

[30]  L. Picker,et al.  Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. , 2002, The Journal of infectious diseases.

[31]  D. Fremont,et al.  Recognition of a virus-encoded ligand by a natural killer cell activation receptor , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Huber,et al.  Human Cytomegalovirus US7, US8, US9, and US10 Are Cytoplasmic Glycoproteins, Not Found at Cell Surfaces, and US9 Does Not Mediate Cell-to-Cell Spread , 2002, Journal of Virology.

[33]  P. Tomasec,et al.  UL40-mediated NK evasion during productive infection with human cytomegalovirus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Busch,et al.  MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo , 2002, Nature Immunology.

[35]  L. Lanier,et al.  Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors , 2002, Science.

[36]  T. Schall,et al.  Potent Immunosuppressive Activities of Cytomegalovirus- Encoded Interleukin-10 , 2002, Journal of Virology.

[37]  C. Sutherland,et al.  UL16-Binding Proteins, Novel MHC Class I-Related Proteins, Bind to NKG2D and Activate Multiple Signaling Pathways in Primary NK Cells , 2002, The Journal of Immunology.

[38]  U. Koszinowski,et al.  The Multiple Immune-Evasion Genes of Murine Cytomegalovirus Are Not Redundant , 2001, The Journal of experimental medicine.

[39]  U. Koszinowski,et al.  The Murine Cytomegalovirus Immune Evasion Protein m4/gp34 Forms Biochemically Distinct Complexes with Class I MHC at the Cell Surface and in a Pre-Golgi Compartment1 , 2001, The Journal of Immunology.

[40]  S. Riddell,et al.  Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells , 2001, Nature Immunology.

[41]  Daniel L. Popkin,et al.  Novel Cell Type–Specific Antiviral Mechanism of Interferon γ Action in Macrophages , 2001, The Journal of experimental medicine.

[42]  R. Armitage,et al.  ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. , 2001, Immunity.

[43]  M. Blok,et al.  The r144 Major Histocompatibility Complex Class I-Like Gene of Rat Cytomegalovirus Is Dispensable for both Acute and Long-Term Infection in the Immunocompromised Host , 2000, Journal of Virology.

[44]  M. Smyth,et al.  M144, a Murine Cytomegalovirus (Mcmv)-Encoded Major Histocompatibility Complex Class I Homologue, Confers Tumor Resistance to Natural Killer Cell–Mediated Rejection , 1999, The Journal of experimental medicine.

[45]  P. Ghazal,et al.  Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. , 1999, Journal of immunology.

[46]  S. Jonjić,et al.  Cytomegaloviral control of MHC class I function in the mouse , 1999, Immunological reviews.

[47]  D. Cosman,et al.  Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers , 1999, Immunological reviews.

[48]  F. Takei,et al.  Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144. , 1998, Cellular immunology.

[49]  P. Bjorkman,et al.  Modulation of Natural Killer Cell Cytotoxicity in Human Cytomegalovirus Infection: The Role of Endogenous Class I Major Histocompatibility Complex and a Viral Class I Homolog , 1998, The Journal of experimental medicine.

[50]  M. Heise,et al.  Murine Cytomegalovirus Inhibits Interferon γ–induced Antigen Presentation to CD4 T Cells by Macrophages Via Regulation of Expression of Major Histocompatibility Complex Class II–associated Genes , 1998, The Journal of experimental medicine.

[51]  H. Vally,et al.  Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo , 1997, Nature.

[52]  O. Mandelboim,et al.  The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells , 1997, Nature.

[53]  J. Xu,et al.  Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[54]  William Arbuthnot Sir Lane,et al.  The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. , 1995, Immunity.

[55]  L. Sun,et al.  Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains , 1995, Journal of virology.

[56]  H. Hengel,et al.  MHC Class I–Subversive Gene Functions of Cytomegalovirus and their Regulation by Interferons–an Intricate Balance , 2004, Virus Genes.

[57]  K. Früh,et al.  Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. , 2004, Immunity.

[58]  J. Bennink,et al.  A survival game of hide and seek: cytomegaloviruses and MHC class I antigen presentation pathways. , 2003, Viral immunology.

[59]  D. McGeoch,et al.  The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. , 2003, The Journal of general virology.

[60]  David C. Johnson,et al.  Human Cytomegalovirus US 2 Causes Similar Effects on Both Major Histocompatibility Complex Class I and II Proteins in Epithelial and Glial Cells , 2003 .

[61]  U. Koszinowski,et al.  Strategies for the identification and analysis of viral immune-evasive genes--cytomegalovirus as an example. , 2002, Current topics in microbiology and immunology.

[62]  P. Tomasec,et al.  Viral evasion of natural killer cells during human cytomegalovirus infection. , 2002, Current topics in microbiology and immunology.

[63]  M. Kikkert,et al.  The HCMV gene products US2 and US11 target MHC class I molecules for degradation in the cytosol. , 2002, Current topics in microbiology and immunology.

[64]  F. Momburg,et al.  Corking the bottleneck: the transporter associated with antigen processing as a target for immune subversion by viruses. , 2002, Current topics in microbiology and immunology.

[65]  D. Sedmak,et al.  Human cytomegalovirus inhibition of major histocompatibility complex transcription and interferon signal transduction. , 2002, Current topics in microbiology and immunology.

[66]  M. Kretzler,et al.  Interaction of DAP3 and FADD only after cellular disruption , 2002, Nature Immunology.

[67]  Luiza Helena Falleiros-Carvalho [Cytomegalovirus (CMV).]. , 1999, Jornal de pediatria.